Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of patients with endometrial carcinoma using the ProMise classifier: a pilot study from India.

Archives of gynecology and obstetrics - 1 Apr 2024

Dahiya Alka, Rajadurai Abarna, Daniel Sherin, Sebastian Ajit, Thomas Dhanya Susan, Thomas Vinotha, George Rachel, Ram Thomas Samuel, Sathyamurthy Arvind, Rebekah Grace, Peedicayil Abraham, Pai Rekha, Thomas Anitha

Abstract excerpt

BACKGROUND: Molecular subtyping of endometrial carcinomas (EC) has been shown to classify tumors into prognostically relevant groups. Characterizing EC with a limited number of markers viz., POLE mutations, p53 mutations, and MMR status, can provide valuable information. DESIGN: Paraffin sections of a cohort of 48 EC from a tertiary care center were characterized for the above-mentioned molecular markers and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial and Cervical Cancer Treatments
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gynecological conditions and treatments

Share to Mutation

Share to Pilot Projects

Share to Prognosis

Share to Survival Analysis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 37707553
DOI: 10.1007/s00404-023-07204-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of patients with endometrial carcinoma using the ProMise classifier: a pilot study from India.PMID 37707553Read ↗

Implementation of the ProMisE classifier and validation of its prognostic impact in Brazilian endometrial carcinomasSemantic proximity Read ↗

Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.Semantic proximity Read ↗

A Pilot study of POLE mutations in endometrial cancer and its clinicopathological correlation with Microsatellite Instability and P53 mutationsSemantic proximity Read ↗

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.Semantic proximity Read ↗

Molecular subtypes and survival patterns of endometrial cancer in a South Indian cohort.Semantic proximity Read ↗

Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia.Semantic proximity Read ↗

Harmonized molecular classification; assessment of a single-test ProMisE NGS tool.Semantic proximity Read ↗

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment DecisionsSemantic proximity Read ↗

Molecular classification of endometrial carcinoma, is it the new era of precision medicine?Semantic proximity Read ↗

Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer.Semantic proximity Read ↗

Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier.Semantic proximity Read ↗

[Molecular classification of endometrial carcinoma-a short summary for clinical use].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.